Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jun 18 04:00PM ET
31.56
Dollar change
-0.28
Percentage change
-0.88
%
IndexRUT P/E25.21 EPS (ttm)1.25 Insider Own1.41% Shs Outstand163.74M Perf Week-0.41%
Market Cap5.17B Forward P/E17.11 EPS next Y1.84 Insider Trans-1.32% Shs Float161.44M Perf Month-4.62%
Income213.77M PEG2.96 EPS next Q0.38 Inst Own102.70% Short Float3.58% Perf Quarter-8.57%
Sales5.19B P/S1.00 EPS this Y1.77% Inst Trans-3.00% Short Ratio2.94 Perf Half Y34.36%
Book/sh8.25 P/B3.83 EPS next Y14.69% ROA6.52% Short Interest5.77M Perf Year13.24%
Cash/sh1.05 P/C30.16 EPS next 5Y8.51% ROE15.38% 52W Range21.39 - 35.53 Perf YTD36.03%
Dividend Est.- P/FCF14.94 EPS past 5Y- ROIC8.40% 52W High-11.17% Beta0.75
Dividend TTM- Quick Ratio1.02 Sales past 5Y16.69% Gross Margin18.82% 52W Low47.55% ATR (14)0.82
Dividend Ex-Date- Current Ratio1.54 EPS Y/Y TTM-17.76% Oper. Margin6.40% RSI (14)45.54 Volatility0.76% 1.50%
Employees6015 Debt/Eq0.91 Sales Y/Y TTM16.98% Profit Margin4.12% Recom1.27 Target Price38.56
Option/ShortYes / Yes LT Debt/Eq0.88 EPS Q/Q9.88% Payout0.00% Rel Volume1.39 Prev Close31.84
Sales Surprise6.00% EPS Surprise18.52% Sales Q/Q16.31% EarningsApr 29 BMO Avg Volume1.97M Price31.56
SMA20-1.08% SMA50-1.91% SMA2006.10% Trades Volume2,734,822 Change-0.88%
Date Action Analyst Rating Change Price Target Change
Apr-30-25Upgrade UBS Neutral → Buy $40
Jan-23-25Upgrade Jefferies Hold → Buy $26 → $35
Jan-13-25Upgrade BofA Securities Neutral → Buy $26 → $33
Dec-05-24Initiated UBS Neutral $26
Nov-04-24Downgrade Goldman Buy → Neutral $27
Oct-31-24Downgrade Jefferies Buy → Hold $38 → $26
Oct-30-24Downgrade BofA Securities Buy → Neutral $43 → $29
Jul-16-24Initiated JMP Securities Mkt Outperform $36
Feb-27-23Resumed Jefferies Buy $38
Jul-19-21Upgrade Goldman Neutral → Buy $20 → $25
Jun-10-25 03:00PM
Jun-04-25 11:35PM
May-11-25 05:16PM
May-08-25 12:35AM
May-06-25 03:20PM
02:48PM Loading…
May-05-25 02:48PM
12:35AM
May-02-25 12:45PM
11:40AM
May-01-25 04:05PM
Apr-30-25 03:10AM
02:56AM
Apr-29-25 12:29PM
08:05AM
07:32AM
07:04AM Loading…
07:04AM
07:00AM
Apr-28-25 03:03AM
Apr-25-25 01:42PM
08:51AM
Apr-24-25 12:50PM
04:17AM
Apr-22-25 01:29PM
05:20AM
Apr-21-25 05:04AM
Apr-17-25 01:50PM
05:19AM
Apr-16-25 10:25AM
Apr-15-25 04:00AM
Apr-14-25 11:40AM
10:44AM Loading…
Apr-13-25 10:44AM
Apr-11-25 11:46AM
06:21AM
Apr-09-25 12:31PM
08:59AM
Apr-03-25 01:09PM
01:59AM
Apr-01-25 05:28AM
Mar-31-25 08:05AM
Mar-28-25 11:06AM
Mar-25-25 09:15AM
Mar-24-25 04:05PM
12:45PM
Mar-21-25 05:05AM
Mar-20-25 11:40AM
Mar-19-25 05:03AM
Mar-14-25 09:01AM
Mar-13-25 05:04AM
Mar-12-25 05:02AM
Mar-07-25 12:45PM
Mar-06-25 08:03AM
Mar-05-25 08:05AM
08:00AM
Mar-04-25 12:20PM
09:15AM
Feb-28-25 09:55AM
Feb-27-25 02:09AM
Feb-26-25 08:17AM
08:05AM
07:11AM
07:00AM
Feb-25-25 08:02AM
Feb-14-25 04:03AM
04:03AM
04:01AM
Feb-13-25 01:13PM
04:01AM
Feb-11-25 04:03AM
04:02AM
Feb-06-25 11:08AM
Feb-02-25 04:32PM
Jan-29-25 12:10PM
Jan-26-25 03:11AM
Jan-25-25 07:26AM
Jan-14-25 09:58AM
Jan-13-25 10:35AM
07:05AM
Dec-04-24 04:05PM
Nov-06-24 04:05PM
Nov-04-24 02:06PM
Oct-31-24 03:07AM
02:57AM
Oct-30-24 08:15AM
07:15AM
07:00AM
Oct-02-24 04:05PM
Aug-01-24 09:40AM
05:24AM
02:02AM
Jul-31-24 08:20AM
07:20AM
07:00AM
Jul-22-24 08:28AM
Jul-17-24 05:26PM
Jul-08-24 04:05PM
Jun-28-24 08:03AM
Jun-27-24 02:14PM
02:03PM
Jun-26-24 10:12PM
Jun-03-24 12:00PM
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients' homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smyser CollinGC & Corporate SecretaryMay 19 '25Option Exercise0.0011,196089,715May 21 04:17 PM
Bavaro MichaelChief Human Resources OfficerFeb 28 '25Option Exercise25.4314,739374,78475,970Mar 03 05:52 PM
Bavaro MichaelChief Human Resources OfficerFeb 28 '25Sale33.2630,9961,030,84344,974Mar 03 05:52 PM
Bavaro MichaelOfficerFeb 28 '25Proposed Sale33.2330,9961,029,900Feb 28 03:41 PM
RADEMACHER JOHN CHARLESChief Executive OfficerFeb 21 '25Option Exercise0.0011,0870772,073Feb 24 08:13 PM
SHAPIRO MICHAEL H.Chief Financial OfficerFeb 17 '25Option Exercise0.003,6520260,487Feb 19 06:17 PM
KRAEMER HARRY M JANSEN JRDirectorNov 08 '24Buy22.5443,000969,031326,334Nov 13 05:27 PM
RADEMACHER JOHN CHARLESChief Executive OfficerOct 26 '24Option Exercise0.0031,2160627,615Oct 29 04:23 PM
SHAPIRO MICHAEL H.Chief Financial OfficerOct 21 '24Option Exercise0.0017,0880264,405Oct 23 05:59 PM
Pate R CarterDirectorSep 03 '24Sale32.371,46547,42136,126Sep 05 04:21 PM
SHAPIRO MICHAEL H.Chief Financial OfficerAug 22 '24Option Exercise18.9723,217440,426270,534Aug 23 05:27 PM
SHAPIRO MICHAEL H.Chief Financial OfficerAug 22 '24Sale30.9523,217718,501247,317Aug 23 05:27 PM
BETTEN ELIZABETH QUADROSDirectorAug 21 '24Sale31.0947,5311,477,53021,339Aug 22 07:38 PM
SULLIVAN TIMOTHY PDirectorAug 22 '24Sale30.9147,2491,460,58920,814Aug 22 07:36 PM
SHAPIRO MICHAEL H.OfficerAug 22 '24Proposed Sale32.0023,217743,000Aug 22 12:55 PM
SULLIVAN TIMOTHY PDirectorAug 22 '24Proposed Sale31.0047,2491,464,719Aug 21 05:43 PM
BETTEN ELIZABETH QUADROSDirectorAug 21 '24Proposed Sale32.0047,5311,521,000Aug 21 01:36 PM
Bavaro MichaelChief Human Resources OfficerAug 15 '24Option Exercise24.935,765143,70349,193Aug 19 04:23 PM
Bavaro MichaelChief Human Resources OfficerAug 15 '24Sale31.425,765181,13643,428Aug 19 04:23 PM
Bavaro MichaelOfficerAug 15 '24Proposed Sale32.005,765184,480Aug 15 12:56 PM